Intracoronary radiotherapy for prevention of restenosis after percutaneous coronary interventions.
More than 50 different pharmacological and mechanical interventions have been tested to date for prevention of vascular restenosis without success. Intracoronary radiotherapy is the first one showing promise of significantly attenuating neointimal proliferation, causing positive vascular remodelling and thus inhibiting restenosis. This promising modality has moved from animal experiments via safety and feasibility testing into the phase of clinical trials of efficacy in large numbers of patients. While ongoing research continues to search for new sources and delivery techniques, currently available technology is being optimized. The randomized clinical trials conducted to date have shown consistently a reduction of target site restenosis rates by 55-79%. Lower incidence of major adverse cardiac events after radiotherapy has also been demonstrated, primarily as a result of reduction in target site and target vessel revascularization rates. However, experimental and clinical research has identified two major complications of this approach: stenosis at the ends of the radiation zone ('edge effect' or 'candywrapper') as well as late thrombosis (beyond 30 days after intervention) of the angioplasty or stent site. If these two adverse effects can be minimized, intracoronary radiotherapy may prove to be a major breakthrough in percutaneous coronary interventions.
Kaluza
G L
GL
The Methodist Hospital and Baylor College of Medicine, Houston, TX 77030, USA.
Ali
N M
NM
Raizner
A E
AE
D000818:Animals; D002986:Clinical Trials as Topic; D017023:Coronary Angiography; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans